Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.
Rogo is the secure, state-of-the-art Generative AI platform purpose-built for elite financial institutions. Trusted by thousands of investment bankers, asset managers, and private equity professionals, Rogo streamlines workflows, rapidly unlocks strategic insights, and saves valuable time—all within the industry's most rigorous security standards. Empower your team to analyze, automate, and innovate with confidence
Jones
Series B in 2025
Jones is a software company that helps real estate and construction companies to remove insurance risk across every property, project, and application. We believe that real estate and construction managers in the built world can make smarter, faster decisions about risk transfer. To realize this vision, we provide our clients with software, data, and insights to unlock the intelligence for better decision making. We call it “Risk Intelligence”.
Speak
Series C in 2024
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.
Vitara Biomedical
Series B in 2024
Vitara Biomedical develops a therapeutic platform to support premature infants. It offers natural physiological processes and hopes to transform neonatal care for newborns and their families into a lifetime of possibilities.
LuxWall
Series B in 2024
LuxWall is a building materials company that pioneers the design and manufacture of vacuum-insulated glass. LuxWall produces glass that acts as transparent insulation, providing thermal insulation values comparable to fiberglass wall insulation. With widespread adoption, LuxWall's patented technology has the potential to reduce global carbon emissions by more than 0.5 gigatonnes per year. The company was founded in 2020 and is headquartered in Ypsilanti, Michigan, United States.
Imprint
Series C in 2024
Imprint is a company specializing in co-branded credit cards, focusing on creating a modern payment platform that enhances user experience and rewards. Imprint partners with various consumer brands to develop loyalty credit cards that provide unique rewards tailored to users' preferences. Imprint's digital cardholder experience and purposefully designed technology stack offer customized programs and rewards for each brand. Imprint tailors the level of program integration to meet the specific needs of each brand.
Fortera
Series C in 2024
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.
Waabi
Series B in 2024
Waabi is an artificial intelligence company based in Toronto, Canada, focused on developing autonomous driving technology for the transportation sector. Founded in 2021 by Raquel Urtasun, Waabi offers a self-driving solution called the Waabi Driver, specifically designed for integration with trucks. The company's technology aims to facilitate large-scale commercialization and safe deployment of autonomous vehicles in the logistics and transportation industries. By utilizing advanced deep learning, probabilistic inference, and complex optimization techniques, Waabi's software is capable of complex reasoning and is end-to-end trainable. This approach allows clients to test driving scenarios and safety-critical edge cases in a closed-loop simulator, significantly reducing the need for extensive real-world testing and enhancing safety and cost-effectiveness in the deployment of autonomous trucking solutions.
Found
Series C in 2024
Found provides business banking services for self-employed people that makes self-employed taxes easy. With built-in expense tracking and a tax savings account, we’re on a mission to help millions of self-employed people make their business dreams a reality.
Cyberhaven
Series C in 2024
Cyberhaven is a data security company focused on enhancing the protection of sensitive information from theft and misuse. The company's innovative platform utilizes advanced data tracing technology to analyze billions of events related to each piece of data, allowing for a comprehensive understanding and classification of sensitive information. This capability enables Cyberhaven to protect a wider range of data types in various forms as they move across networks. By assessing internal actions within enterprises, the platform identifies risky behaviors and practices, helping to prevent security breaches. Additionally, it provides full-context data tracing to minimize false positives and negatives, thereby streamlining incident response investigations. Overall, Cyberhaven aims to simplify and strengthen enterprise security, ensuring that organizations can safeguard their critical information effectively.
PolyAI
Series C in 2024
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.
Glydways
Series B in 2024
Glydways, formerly known as Wayfarer, is a transportation technology and clean energy company located in South San Francisco, California. The company focuses on designing, manufacturing, installing, and operating affordable autonomous transportation systems that cater to various capacity needs, including low, medium, and extremely high-capacity demands. Glydways aims to transform mobility and public transportation by providing a system that operates profitably at existing mass transit fares. Its solutions are designed for efficiency, featuring a small physical and environmental footprint, with zero greenhouse gas emissions. By offering a personal, private car experience, Glydways enhances passenger capacity while minimizing costs and environmental impact.
Li Industries
Series B in 2024
Li Industries is a start-up dedicated to advancing lithium-ion battery recycling technologies. The company focuses on reclaiming materials from end-of-life batteries used in electric vehicles, consumer electronics, and various energy storage systems. By utilizing direct recycling technology, Li Industries specializes in recovering valuable metals such as lithium, cobalt, and nickel, which are essential for battery production. Their innovative electrochemical flow system allows for non-destructive lithiation and optimizes the post-treatment of recovered materials, enhancing the efficiency of the recycling process. Through its efforts, Li Industries aims to minimize environmental waste, lower emissions, and reduce the costs associated with lithium-ion battery manufacturing, thereby promoting a more sustainable supply chain for battery materials.
Rad AI
Series B in 2024
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.
Anrok
Series B in 2024
Anrok is a sales tax software solution tailored for SaaS businesses, providing a comprehensive platform for monitoring, calculating, and remitting sales tax across various financial systems. The software streamlines the sales tax process by automating the manual tasks typically associated with tax management, helping clients minimize errors and reduce expenses related to sales tax and value-added tax. Anrok's features include customizable configurations, filing frequency alerts, and enhanced visibility, all designed to facilitate accurate tax handling. This unified approach allows finance teams in organizations of all sizes to manage their tax obligations efficiently, generate audit-ready reports, and maintain compliance effectively.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Varda
Series B in 2024
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.
Skyflow
Series B in 2024
Skyflow, Inc. is a technology company based in Los Altos, California, that specializes in providing a privacy API for managing sensitive user information, such as social security numbers. Founded in 2017 and formerly known as Prekari Labs, the company has developed a secure data privacy platform that integrates a customer data vault to help businesses handle personally identifiable information (PII) in compliance with various regulations, including PCI, HIPAA, GDPR, and CCPA. Skyflow's platform utilizes advanced encryption and tokenization techniques to protect sensitive data across different applications, ensuring that businesses can securely manage, store, and access this information while maintaining the privacy and security of their customers.
Loyal
Series B in 2024
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
CureSkin
Series B in 2024
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.
Siolta Therapeutics
Series C in 2024
Siolta Therapeutics, Inc. is a clinical-stage biotech company based in San Francisco, California, focused on developing microbiome-based therapeutics and diagnostics aimed at preventing and treating chronic inflammatory diseases, particularly asthma and atopic conditions. Founded in 2016, the company utilizes its expertise in the developing gut microbiome to promote immune tolerance. Siolta's platform includes the development of pharmaceutical-grade anaerobic organisms and microbiome-based diagnostics that support precision medicine. By leveraging insights from human microbiome studies, Siolta Therapeutics aims to create targeted microbial therapeutics that address the underlying causes of inflammatory diseases, enabling a new approach to prevention and treatment.
Inkitt
Series C in 2024
Inkitt GmbH operates an online community that connects writers and readers, facilitating the sharing and promotion of stories across various genres, including horror, romance, and sci-fi. Founded in 2013 and based in Berlin, the company publishes books using crowd wisdom and data-driven insights to predict future bestsellers. Its core platform, Inkitt, allows authors to share their works in progress and receive feedback from readers, who can access these manuscripts for free for a limited time. In addition to Inkitt, the company also operates Galatea, which sells optimized stories in a chapter-by-chapter format, and GalateaTV, which adapts successful e-books into short-form television series. Inkitt's proprietary ReadRank algorithm identifies high-potential stories, enhancing the overall user experience and driving its publishing success. The company aims to leverage AI for hyper-personalization, tailoring stories to individual reader preferences across multiple media formats.
Koloma
Series B in 2024
Koloma is a geologic hydrogen company focused on identifying and commercializing geologic hydrogen resources. By utilizing its technology and proprietary data, Koloma develops data-driven solutions for energy transition resource development. The company's initiatives aim to reduce global carbon emissions, providing businesses with the tools to lower their carbon footprint and contribute to climate change mitigation efforts. Through its innovative approach, Koloma seeks to advance clean energy technology and support the transition towards a more sustainable energy future.
Eligo Bioscience
Series B in 2023
Eligo Bioscience S.A.S is a biotechnology company based in Paris, France, that specializes in the development of Eligobiotics, a new class of antimicrobials designed to target specific bacteria based on their genetic makeup. Founded in 2014, the company utilizes a combination of CRISPR/Cas technology and engineered phage capsids to create antibiotics capable of addressing microbiome-related diseases and combating resistant pathogens. These programmed antimicrobials aim to eradicate virulent bacteria within the human microbiome, facilitating the creation of advanced therapeutics for conditions caused by superbugs. Eligo Bioscience's innovative approach positions it at the forefront of microbiome precision therapies and next-generation antibiotic solutions.
Tabnine
Series B in 2023
Tabnine, Inc. is an artificial intelligence company based in Toronto, Canada, that specializes in autocompletion software for developers. Founded in 2018, Tabnine offers an AI-powered coding assistant designed to help development teams enhance their coding efficiency while maintaining privacy and security. The platform predicts and autocompletes lines of code based on context and learned programming patterns, enabling developers to write software more seamlessly. Additionally, it includes features for analyzing code snippets and leveraging open-source code effectively. Tabnine's capabilities extend to providing an AI chat agent that can explain code and generate code, tests, and documentation from plain language prompts, thereby reducing errors and streamlining the software development process. Tabnine operates as a subsidiary of Codota Dot Com Ltd.
Glydways
Series B in 2023
Glydways, formerly known as Wayfarer, is a transportation technology and clean energy company located in South San Francisco, California. The company focuses on designing, manufacturing, installing, and operating affordable autonomous transportation systems that cater to various capacity needs, including low, medium, and extremely high-capacity demands. Glydways aims to transform mobility and public transportation by providing a system that operates profitably at existing mass transit fares. Its solutions are designed for efficiency, featuring a small physical and environmental footprint, with zero greenhouse gas emissions. By offering a personal, private car experience, Glydways enhances passenger capacity while minimizing costs and environmental impact.
Farther
Series B in 2023
Farther is a technology-driven wealth management firm founded in 2019, focusing on high-net-worth individuals seeking a holistic approach to financial management. The firm combines expert financial advisors with advanced technology to enhance the client experience and deliver personalized investment advice. Farther's platform provides tailored recommendations on exchange-traded funds (ETFs) by utilizing a proprietary algorithm that creates model portfolios based on individual client information, financial situations, and risk tolerance. This data-driven approach allows advisors to offer comprehensive strategies that aim for both capital preservation and growth over the long term. Farther seeks to redefine wealth management standards by integrating personal service with modern analytics, ensuring clients receive informed and effective financial guidance.
Mighty Buildings
Series B in 2023
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.
Viome
Series C in 2023
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.
GAIL
Series B in 2023
GAIL is a generative AI solution for insurance agencies. It provides a multilingual AI capable of communicating via speech, SMS, email, and WhatsApp. It also provides recordings, transcripts, analytics, and follows up with callers with any necessary deliverables.
Neon
Series B in 2023
Neon is a cloud-native, fully managed Postgres as a service. By separating storage from computing, Neon offers autoscaling, branching, and bottomless storage to give developers a simple, reliable, and powerful experience. Neon aims to provide a highly performant and cost-effective database infrastructure by leveraging cloud-native technologies and innovative architectural features.
SURGE Therapeutics
Series B in 2023
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.
Speak
Series B in 2023
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.
TeraWatt Technology
Series C in 2023
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.
Ceibo
Series B in 2023
Ceibo is an industrial biotechnology company dedicated to providing innovative solutions for the mining industry, particularly in the production of critical minerals essential for the clean energy transition. The company has developed proprietary technology for leaching copper sulfide, which enhances recovery from both primary and secondary sulfide ores rich in chalcopyrite. In addition to its leaching technology, Ceibo has implemented technologies aimed at dust suppression in mining operations. Currently, Ceibo operates within several large mining assets owned by prominent mining companies, focusing on optimizing processes, reducing costs, and promoting environmentally sustainable practices with a commitment to zero waste activity.
Nomba
Series B in 2023
Nomba is a fintech company focused on providing accessible and affordable financial software solutions for businesses in Africa. The company offers a range of services, including business savings accounts, joint savings options, card payments, and POS terminal management. Nomba's platform enables users to perform various financial transactions, such as paying bills, transferring money, purchasing airtime and TV subscriptions, and managing electricity payments. Customers can engage with Nomba's services through multiple digital channels, including mobile, web, and USSD, as well as through a network of agents. By streamlining these financial processes, Nomba aims to enhance the financial capabilities of businesses and individuals across the continent.
Replit
Series B in 2023
Replit is a browser-based integrated development environment (IDE) designed to make coding accessible to a wide audience. Founded in 2016 and headquartered in San Francisco, California, Replit supports over 50 programming languages, enabling users to build applications and websites directly from their browsers, regardless of the operating system or device used. The platform facilitates real-time collaboration, allowing multiple users to work together on projects, and provides features for deploying, saving, and sharing code seamlessly online. By offering an intuitive and powerful toolset, Replit aims to simplify the coding experience for both novice and experienced developers.
Lexion
Series B in 2023
Lexion is a Seattle-based company that specializes in developing a software-as-a-service (SaaS) application leveraging artificial intelligence and natural language processing to enhance contract management. Its system organizes contracts in a centralized platform, automatically reading and interpreting legal terms, policies, and documents. By extracting key information such as termination notices, renewal dates, and payment terms, Lexion provides businesses with valuable insights and ensures critical contract obligations are tracked efficiently. The software integrates with various business, storage, and signature systems, streamlining workflows and enabling companies to save time and money through improved contract oversight.
Mojo Vision
Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Fulfil Solutions
Series B in 2023
Fulfil develops a custom automation robotics system built to solve food supply chain challenges. Fulfil's mission is to reduce waste, environmental impact, and emissions with truly new technology. Fulfil addresses challenges at the intersection of mechanical design, software, robotics, computer vision, and deep learning.
Light Field Lab
Series B in 2023
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.
IgGenix
Series B in 2023
IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.
Synchron
Series C in 2022
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.
Bionaut Labs
Series B in 2022
Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.
Viome
Series C in 2022
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.
Proclaim
Series B in 2022
Proclaim is a developer of a oral care platform designed to prevent oral diseases.
Vitara Biomedical
Series B in 2022
Vitara Biomedical develops a therapeutic platform to support premature infants. It offers natural physiological processes and hopes to transform neonatal care for newborns and their families into a lifetime of possibilities.
PolyAI
Series B in 2022
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.
Prellis Biologics
Series C in 2022
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.
Truework
Series C in 2022
Truework is a platform that facilitates the verification of income and employment for banks, lenders, and other entities. By integrating with human resources and payroll systems, as well as sectors like lending and housing, the platform automates the processing of employment and income requests. This capability allows financial institutions and background check providers to efficiently approve or deny requests for verification. Truework emphasizes consumer control over personal data, positioning itself as a key player in the financial services and fintech sectors. Its API-enabled solution streamlines the verification process, enhancing efficiency for users in need of reliable employment and income information.
TeraWatt Technology
Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.
Oobli
Series B in 2022
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
Loop
Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Ellevest
Series B in 2022
Ellevest, Inc. is an investment management firm founded in 2014 and based in New York City, focusing primarily on providing financial services to women. The firm manages customized client portfolios across various asset classes globally, employing fundamental analysis and a top-down approach in its investment strategy. Ellevest has developed a digital investment platform that offers a personalized experience, utilizing proprietary algorithms tailored to women's financial needs, including salary peaks and goal-specific portfolios. This platform aims to empower female investors by helping them take control of their investments and achieve their financial goals through a user-friendly interface and thoughtful portfolio construction.
WorldCoin
Series B in 2022
World is a company that connects users through a privacy-focused network designed for secure digital asset management. It offers a digital currency platform that emphasizes both privacy and transparency using a permissionless blockchain. The World App enables users to securely store their World ID, manage digital assets, and access various Mini Apps, promoting global connectivity and trust. Additionally, World provides an iris-scanning device that enhances digital identity security by storing biometric information, which helps discourage spammers from creating multiple accounts. This combination of secure identity management and digital currency aims to facilitate a reliable and user-friendly digital environment.
Hermeus
Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.
Homebound
Series C in 2022
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.
Polly
Series B in 2022
The secondary market for mortgages accounts for over $1T in annual volume and impacts 20% of GDP. Yet, the pricing and loan trading of mortgages is still often done with antiquated technology, excel spreadsheets, phone calls, and physical paper. Billions of dollars are lost to inefficiency and mistakes. Polly is transforming the mortgage industry with its modern, data-driven capital markets ecosystem that includes an advanced Product & Pricing Engine (PPE), Loan Trading Exchange, Analytics Platform, and Partner Platform. Our mission is to help capital markets and secondary teams operate smarter, more efficiently, and more profitably with best-in-class, end-to-end technology that is configured for each of our customers’ unique workflows and business needs. Polly is based in San Francisco, California. Please visit www.polly.io to learn more.
Prellis Biologics
Series B in 2021
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.
Robin Healthcare
Series B in 2021
Robin Healthcare, Inc. is a healthcare technology company that focuses on enhancing the medical industry through innovative software solutions. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company provides a range of services including clinical documentation solutions, medical scribe services, order and medication entry, chart review, billing and coding, and referral management. By integrating technology with trained medical scribes, Robin Healthcare aims to streamline administrative tasks and improve the doctor-patient experience, allowing healthcare professionals to dedicate more time to patient care while maintaining control over their practices.
CloudTrucks
Series B in 2021
CloudTrucks develops a virtual trucking carrier application designed to reduce operating costs for truck drivers. The platform helps to manage and book loads from brokers and shippers, offer instant payments after load delivery, and access to cheap insurance options, enabling truck owners and operators to strategize their schedule and design a revenue-maximizing driving program. The company was founded in 2019 and is headquartered in San Francisco, California.
Lessen
Series B in 2021
Lessen is a technology-driven company that offers an end-to-end solution for outsourced real estate property services, focusing on single-family and multifamily rental renovations, turns, and maintenance. Through its proprietary technology platform, Lessen provides real estate owners with on-demand resources, predictable service costs, and efficient job verification for essential services such as cleaning, laundry, and repairs. The company's professional field project managers utilize real-time analytics and a network of vetted service providers across over 40 markets to ensure consistent quality and speed in project management. By modernizing traditional organizational and communication methods, Lessen aims to streamline the management of real estate rental assets and enhance the overall client experience.
Up&Up
Series B in 2021
Up&Up is a New York-based platform that facilitates fractional homeownership, providing a unique approach to renting and owning a home. Founded in 2017, the company allows renters to invest in their rental properties, enabling them to benefit from home price appreciation and accumulate ownership stakes through their rent payments. This model aims to make homeownership more accessible and flexible, allowing residents to build equity while maintaining the convenience of renting. By offering a rewarding alternative to traditional rental agreements, Up&Up helps individuals work towards their homeownership goals while also minimizing maintenance and property management costs.
OpenStore
Series B in 2021
OpenStore connects merchants and customers into a single unified shopping experience through access to data, information, and capital. The company aims to offer instant liquidity for eCommerce entrepreneurs.
Heyday
Series C in 2021
Heyday is a skincare services company that provides customized facial treatments through its chain of stores, which are primarily located in New York. Founded in 2015 by Adam Ross, Jeni Sykes, and Michael Pollak, Heyday focuses on offering a personalized skincare experience, including deep cleansing, skin analysis, exfoliation, extractions, masks, hydration, and SPF protection. In addition to its core services, the company also enables customers to purchase a range of skincare products at competitive prices. With a commitment to blending expertise and data, Heyday empowers individuals to take better care of their skin. The company operates an online platform that accelerates consumer product brands on digital marketplaces, further enhancing its reach and impact in the skincare industry.
Viome
Series C in 2021
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. The company specializes in wellness monitoring kits that offer comprehensive health insights by analyzing various biological samples, including blood, urine, saliva, and stool. By examining the RNA from stool samples, Viome determines the composition of microbial communities in the digestive system, identifying different species and strains of bacteria, viruses, fungi, and other microorganisms. This analysis is integrated into a smartphone application that provides personalized recommendations for diet and lifestyle adjustments, aiding users in tracking their microbiome health, mitochondrial health, cellular health, and biological age. Viome's products are available through distributors and online, positioning the company as a leader in personalized health solutions.
Because Market
Series B in 2021
Because Market is a direct-to-consumer personal care company established in 2017, specializing in products tailored for older adults. The company aims to simplify access to essential health and wellness items, including incontinence underwear, pads, skincare, supplements, and walkers. By providing discreet delivery and flexible subscription options, Because Market facilitates the purchasing process for families seeking to support their senior members. With aspirations to become the most trusted brand in this sector, the company has secured over $40 million in funding from prominent venture capital firms, reflecting its commitment to enhancing the lives of older adults and promoting their independence.
Lightship
Series C in 2021
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.
OpenTrons
Series C in 2021
Opentrons is a company that specializes in the development of automated laboratory equipment, particularly pipetting robots designed to streamline and enhance the efficiency of scientific experiments. By utilizing open-source technology and the Python programming language, Opentrons enables researchers to automate various laboratory processes, thereby reducing the potential for human error and expediting experimental workflows. Their product offerings include lab robots, workstations, hardware modules, consumables, reagents, and labware, all aimed at facilitating a more efficient and accurate research environment.
Statespace
Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Eight Sleep
Series C in 2021
Eight Sleep, Inc. is a sleep technology company based in New York, founded in 2014. It specializes in the manufacturing and sale of smart mattresses that feature advanced temperature control, allowing users to cool or heat each side of the bed according to their preferences. The products are designed to enhance comfort and support optimal rest, health, and daily functioning by tracking heart rate and other health metrics. In addition to smart mattresses, Eight Sleep offers a range of accessories, including sleep trackers, pillows, organic sheets, foundations, waterproof protectors, blue wave glasses, and gravity blankets. The company primarily sells its products online and is recognized for its innovation in the sleep industry, having been named one of the Most Innovative Companies in Consumer Electronics by Fast Company in 2018.
Bungalow
Series C in 2021
Bungalow is a residential real estate platform that facilitates flexible and communal living arrangements for renters, particularly targeting early career professionals. Founded in 2016 by Andrew Collins and Justin McCarty, the company is headquartered in San Francisco, California. Bungalow signs long-term leases with homeowners to offer multi-bedroom homes in desirable urban neighborhoods across the United States. Each property features private bedrooms with handpicked housemates, and comes fully furnished with essential amenities such as Wi-Fi, utilities, and housekeeping. Additionally, Bungalow organizes monthly community events to foster social interaction among residents. By addressing the needs of modern renters, Bungalow provides a convenient solution for those seeking quality living environments while cultivating a sense of community.
Kiddom
Series C in 2021
Kiddom is an education platform that offers a comprehensive digital curriculum designed to enhance the learning experience for students both at home and in the classroom. The platform integrates curriculum management, instruction, assessment, and communication tools into a single solution, streamlining processes for schools and saving valuable time and resources. With its flexible design, Kiddom allows teachers and students to access and modify curriculum from anywhere, effectively supporting various learning scenarios such as in-class, blended, hybrid, and distance education. The user-friendly dashboard enables educators to plan and implement competency-based curricula, assess student work, and engage with students in real-time, fostering community collaboration and improving overall educational outcomes.
Homebase
Series C in 2021
Homebase is a software application that provides tools for employee scheduling, time tracking, communication, and task management. The app facilitates communication between managers and employees through messaging features, allowing for easy coordination and updates regarding shifts, tasks, and announcements. Employees can clock in and out using the app, allowing managers to track hours worked and monitor labor costs in real-time accurately.
Deep Genomics
Series C in 2021
Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI.
HealthifyMe
Series C in 2021
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.
Mighty Buildings
Series B in 2021
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.
AttackIQ
Series C in 2021
AttackIQ, Inc. is a cybersecurity company that specializes in providing a Breach & Attack Simulation (BAS) platform designed to help organizations assess the effectiveness of their security controls. Founded in 2013 and headquartered in San Diego, California, the company offers a platform that integrates with existing networks to deliver insights into security programs, identifying gaps in coverage and misconfigurations. By supporting the MITRE ATT&CK Matrix, AttackIQ enables organizations to simulate real-world attack scenarios, thereby allowing security teams to evaluate their defenses and prioritize remediation efforts effectively. The platform automates security assessments, empowering users to create custom scenarios or utilize a library of pre-defined attacks to continuously test their environments. This approach helps businesses to validate their security measures in a real-world context rather than relying solely on theoretical simulations. AttackIQ also has regional offices in Sydney and Melbourne, Australia, extending its global reach in cybersecurity solutions.
Sword Health
Series C in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.
Fortera
Series B in 2021
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.
Imply
Series C in 2021
Imply, founded by the original creators of Apache Druid, offers a comprehensive real-time analytics platform that leverages the capabilities of Apache Druid, an open-source database designed for next-generation analytics. The platform enables organizations to handle event-driven and streaming data with high scalability and rapid data visualization, allowing decision-makers to access petabyte-scale datasets efficiently. Imply focuses on a category it terms "analytics-in-motion," which emphasizes interactive and cost-effective analytics solutions as opposed to traditional static approaches. By supporting real-time ingestion and analysis, Imply empowers leading companies globally to enhance their business intelligence and operational analytics. The company operates in North America, Europe, and Asia Pacific, receiving backing from notable investors in the technology sector.
Synchron
Series B in 2021
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.
Hello Heart
Series C in 2021
Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to use and helps participants improve their heart health in a fun and engaging way.
Clear Labs
Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Overture Life
Series B in 2021
Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.
Pendulum Therapeutics
Series C in 2021
Pendulum Therapeutics Inc. is a microbiome-focused company based in San Francisco that specializes in developing medical probiotics and prebiotics aimed at managing chronic illnesses, particularly type 2 diabetes. The company's flagship product, Pendulum Glucose Control, was introduced in 2020 and has demonstrated effectiveness in lowering blood sugar spikes and reducing A1C levels, as evidenced by published clinical trials. Pendulum utilizes evidence-based microbiome science and DNA sequencing to create targeted interventions, allowing clinicians to identify specific microbiome markers for disease treatment. Founded in 2013, Pendulum holds 13 patents and has 42 pending, with significant backing from prominent investors. The company sells its products online, focusing on improving healthcare through innovative microbiome therapies.
Rightway
Series C in 2021
Rightway is a technology and services company focused on simplifying healthcare for clients and their members. The company develops care navigation and pharmacy benefit management (PBM) solutions aimed at reducing healthcare spending by guiding members toward optimal care and therapies. Rightway's mission centers on using guidance and advocacy to lower costs and improve healthcare outcomes by aligning incentive models and integrating clinicians into the care journey. Its modern care navigation technology offers clinical guidance at a lower cost compared to traditional solutions. Additionally, Rightway's innovative PBM model ensures that every prescription is directed towards the lowest net cost, thereby minimizing expenses for members. The company’s transparent approach to pharmacy benefits is unique in that it incorporates care navigation, enhancing the overall member experience and engagement while addressing total cost-of-care.
Scipher Medicine
Series C in 2021
Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.
Egenesis
Series C in 2021
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Mighty Buildings
Series B in 2021
Mighty Buildings, Inc. is a construction technology company based in San Francisco, California, founded in 2017. The company specializes in manufacturing 3D printed custom homes, aiming to disrupt the residential housing market through innovative techniques. Utilizing a proprietary building material known as Light Stone Material (LSM), which resembles synthetic stone, Mighty Buildings enhances the construction process by making it faster and eliminating waste. LSM also offers better temperature regulation compared to traditional materials like concrete, wood, or steel. In addition to 3D printing, Mighty Buildings employs robotics and automation to develop prefabricated, environmentally friendly, and climate-resilient homes. The company's approach to modular construction is designed to provide affordable smart housing solutions while supporting urban development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.